bibliographicCitation |
Blakely LJ, Schwartzberg L, Keaton M, Schnell F, Henry D, Epperson A, Walker MS. A phase II trial of pemetrexed and gemcitabine as first line therapy for poor performance status and/or elderly patients with stage IIIB/IV non-small cell lung cancer. Lung Cancer. 2009 Oct;66(1):97–102. doi: 10.1016/j.lungcan.2008.12.017. PMID: 19167130. |